X
Search Filters
Format Format
Format Format
X
Sort by Item Count (A-Z)
Filter by Count
Journal Article (2829) 2829
Newspaper Article (1854) 1854
Publication (379) 379
Patent (354) 354
Conference Proceeding (104) 104
Paper (49) 49
Dissertation (28) 28
Book Chapter (21) 21
Book Review (21) 21
Magazine Article (19) 19
Book / eBook (11) 11
Reference (3) 3
Trade Publication Article (3) 3
Government Document (1) 1
Newsletter (1) 1
more...
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
athletes (1409) 1409
index medicus (488) 488
coaches & managers (470) 470
humans (418) 418
college football (316) 316
animals (300) 300
male (288) 288
female (267) 267
professional football (244) 244
physics (168) 168
analysis (162) 162
adult (154) 154
middle aged (124) 124
tournaments & championships (116) 116
astronomy & astrophysics (109) 109
chemistry (109) 109
mice (108) 108
performing operations (103) 103
transporting (103) 103
college basketball (96) 96
athletic drafts & trades (95) 95
research (94) 94
athletic recruitment (88) 88
oxidative stress (88) 88
astrophysics - solar and stellar astrophysics (87) 87
electricity (87) 87
aged (86) 86
astrophysics (85) 85
professional baseball (85) 85
colleges & universities (84) 84
college sports (80) 80
zoology (80) 80
high school football (79) 79
entomology (77) 77
inflammation (75) 75
neurosciences (73) 73
brazil (72) 72
veterinary sciences (72) 72
spectroscopy (71) 71
metallurgy (70) 70
oncology (67) 67
physics, particles & fields (67) 67
pharmacology & pharmacy (66) 66
galaxy astrophysics (64) 64
professional basketball (63) 63
earth and planetary astrophysics (62) 62
solar and stellar astrophysics (62) 62
stars: fundamental parameters (62) 62
surgery (60) 60
multidisciplinary sciences (59) 59
cancer (58) 58
sports injuries (58) 58
studies (58) 58
stars (56) 56
cosmology and extragalactic astrophysics (55) 55
human necessities (55) 55
nuclear science & technology (55) 55
ecology (53) 53
astrophysics - astrophysics of galaxies (52) 52
biochemistry & molecular biology (52) 52
medicine (52) 52
agriculture (51) 51
medicine & public health (51) 51
risk factors (51) 51
adolescent (50) 50
child (50) 50
chemistry, inorganic & nuclear (49) 49
health aspects (49) 49
instruments & instrumentation (49) 49
microbiology (49) 49
organic chemistry (49) 49
life sciences (48) 48
stars: abundances (47) 47
article (46) 46
cytokines (46) 46
physical sciences (46) 46
sports training (46) 46
antioxidants (44) 44
biology (43) 43
chemistry, physical (43) 43
endocrinology & metabolism (43) 43
obesity (43) 43
pain (43) 43
proteins (43) 43
usage (43) 43
research article (42) 42
heating (41) 41
lighting (41) 41
mechanical engineering (41) 41
physics - solar and stellar astrophysics (41) 41
plant sciences (41) 41
activation (40) 40
blasting (40) 40
care and treatment (40) 40
dentistry, oral surgery & medicine (40) 40
education (40) 40
immunology (40) 40
natural sciences (40) 40
naturvetenskap (40) 40
weapons (40) 40
more...
Library Location Library Location
Language Language
Language Language
X
Sort by Item Count (A-Z)
Filter by Count
English (4645) 4645
French (333) 333
Portuguese (278) 278
German (111) 111
Italian (61) 61
Spanish (31) 31
Japanese (5) 5
Czech (4) 4
Korean (3) 3
Norwegian (3) 3
Chinese (2) 2
Persian (1) 1
Polish (1) 1
more...
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


The New England Journal of Medicine, ISSN 0028-4793, 05/2015, Volume 372, Issue 19, pp. 1791 - 1800
Patients with myocardial infarction 1 to 3 years previously were assigned to ticagrelor, 90 or 60 mg twice daily, or to placebo, in addition to low-dose... 
MEDICINE, GENERAL & INTERNAL | HEART-DISEASE | CLOPIDOGREL | MANAGEMENT | ESC GUIDELINES | AMERICAN-COLLEGE | PREVENTION | ASSOCIATION TASK-FORCE | ACUTE CORONARY SYNDROMES | PRASUGREL | ASPIRIN | Purinergic P2Y Receptor Antagonists - administration & dosage | Double-Blind Method | Drug Administration Schedule | Cardiovascular Diseases - prevention & control | Humans | Middle Aged | Kaplan-Meier Estimate | Male | Risk | Secondary Prevention | Adenosine - administration & dosage | Aspirin - administration & dosage | Purinergic P2Y Receptor Antagonists - adverse effects | Myocardial Infarction - drug therapy | Adenosine - adverse effects | Adenosine - analogs & derivatives | Intracranial Hemorrhages - chemically induced | Platelet Aggregation Inhibitors - administration & dosage | Cardiovascular Diseases - mortality | Female | Aged | Hemorrhage - chemically induced | Drug Therapy, Combination | Platelet Aggregation Inhibitors - adverse effects | Dose-response relationship (Biochemistry) | Treatment outcome | Care and treatment | Safety and security measures | Analysis | Dosage and administration | Ticagrelor | Heart attack | Risk factors | Myocardial infarction | Cerebral infarction | Aspirin | Stroke | Heart attacks | Hemorrhage | Long term | Patients | Thrombolysis | Bleeding | Blood platelets | Antagonist drugs | Cardiovascular diseases | Drug therapy | Life Sciences | Human health and pathology
Journal Article
by Santos, Paloma Marques and Bocchiglieri, Adriana and Chiarello, Adriano Garcia and Paglia, Adriano Pereira and Moreira, Adryelle and Souza, Agnis Cristiane and Abba, Agustin Manuel and Paviolo, Agustin and Gatica, Ailin and Medeiro, Akyllan Zoppi and Costa, Alan Nilo and Gallina, Alberto Gonzalez and Yanosky, Alberto A and Jesus, Alejandro and Bertassoni, Alessandra and Rocha, Alessandro and Bovo, Alex Augusto Abreu and Bager, Alex and Mol, Alexandra Cravino and Martensen, Alexandre Camargo and Faustino, Alexandre Casagrande and Lopes, Alexandre Martins Costa and Percequillo, Alexandre Reis and Vogliotti, Alexandre and Keuroghlian, Alexine and Colina, María Alicia and Devlin, Allison L and García‐Olaechea, Alvaro and Sánchez, Amadeo and Srbek‐Araujo, Ana Carolina and Ochoa, Ana Cecilia and Oliveira, Ana Cristina Mendes and Lacerda, Ana Cristyna Reis and Campelo, Ana Kellen Nogueira and Oliveira Paschoal, Ana Maria and Costa, Ana Raíssa Cunha and Meiga, Ana Yoko Ykeuti and Jesus, Anamélia Souza and Feijó, Anderson and Hirsch, André and Silva, André Luiz Ferreira and Botelho, André Luis Moura and Regolin, André Luis and Lanna, André Monnerat and Nunes, André Valle and Kindel, Andreas and Moraes, Andreia Magro and Gatti, Andressa and Noss, Andrew J and Nobre, Andrezza Bellotto and Montanarin, Anelise and Deffaci, Ângela Camila and Albuquerque, Anna Carolina Figueiredo and Oliveira, Anne Karoline and Mangione, Antonio Marcelo and Pontes, Antonio Rossano Mendes and Bertoldi, Ariane Teixeira and Calouro, Armando Muniz and Desbiez, Arnaud L. J and Fernandes, Arthur and Ferreguetti, Atilla Colombo and Silva, Maria Augusta Andrade and Zimbres, Barbara and Luciano, Beatriz Fernandes Lima and Thoisy, Benoit and Niebuhr, Bernardo Brandão S and Papi, Bernardo and Gómez‐Valencia, Bibiana and Santos, Bráulio A and Lima, Breno Campelo and Oliveira, Bruna Gomes and Santos, Bruna Silva and Campos, Bruno Augusto Torres Parahyba and Leles, Bruno and Albuquerque França, Bruno Rodrigo and Lim, Burton and Oliveira, Caetano Troncoso and Cantagallo, Camila and Lara, Camila Clozato and Lima, Camila Silveira and Gestich, Carla Cristina and Melo‐Soares, Carla Danielle and Peres, Carlos A and Kasper, Carlos Benhur and Candia‐Gallardo, Carlos and De Angelo, Carlos and Fragoso, Carlos Eduardo and Freitas, Carlos Henrique and Salvador, Carlos Henrique and Brocardo, Carlos R and Melo, Carolina Depolito and Leuchtenberger, Caroline and Braga, Caryne and Sánchez‐Lalinde, Catalina and Bueno, Cecília and Luna, Cecília Licarião and Rojano, Cesar and Hurtado, Cindy Meliza and Santos, Cinthya Chiva and Tellaeche, Cintia and ...
Ecology, ISSN 0012-9658, 07/2019, Volume 100, Issue 7, pp. e02663 - n/a
Journal Article
The New England Journal of Medicine, ISSN 0028-4793, 10/2013, Volume 369, Issue 14, pp. 1317 - 1326
Saxagliptin, a new oral antihyperglycemic drug in the DPP-4 inhibitor class, had no effect on the risk of cardiovascular events in patients with type 2... 
ALL-CAUSE | MEDICINE, GENERAL & INTERNAL | METAANALYSIS | EVENTS | GLUCOSE CONTROL | MICROALBUMINURIA | DISEASE | CLINICAL-USE | PREVENTION | RISK | DEATH | Dipeptidyl-Peptidase IV Inhibitors - adverse effects | Dipeptidyl-Peptidase IV Inhibitors - therapeutic use | Humans | Middle Aged | Hospitalization - statistics & numerical data | Male | Adamantane - therapeutic use | Aged, 80 and over | Cardiovascular Diseases - epidemiology | Cardiovascular Diseases - mortality | Female | Hypoglycemia - chemically induced | Heart Failure - epidemiology | Diabetes Mellitus, Type 2 - complications | Adamantane - adverse effects | Adamantane - analogs & derivatives | Hypoglycemic Agents - therapeutic use | Cardiovascular Diseases - etiology | Dipeptides - therapeutic use | Double-Blind Method | Pancreatitis - epidemiology | Dipeptides - adverse effects | Kaplan-Meier Estimate | Pancreatitis - chemically induced | Aged | Diabetes Mellitus, Type 2 - drug therapy | Hypoglycemic Agents - adverse effects | Type 2 diabetes | Complications and side effects | Patient outcomes | Dosage and administration | Drug therapy | Heart diseases | Risk factors | Saxagliptin | Myocardial infarction | Cerebral infarction | Heart attacks | Peptidase | Diabetes mellitus | Pancreatitis | Cardiovascular disease | Angina | Patients | Heart rate | Ischemia | Diabetes | Cardiovascular diseases | Diabetes mellitus (non-insulin dependent)
Journal Article